Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma
Open Access
- 16 June 2020
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 17 (1) , 1-21
Abstract
Background: Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disease. Some children with OMS also have neuroblastoma (NB). We and others have previously documented that serum IgG from children with OMS and NB induces neuronal cytolysis and activates several signaling pathways. However, the mechanisms underlying OMS remain unclear. Here, we investigated whether nitric oxide (NO) from activated microglias and its cascade contribute to neuronal cytolysis in pediatric OMS. Methods: The activation of cultured cerebral cortical and cerebellar microglias incubated with sera or IgG isolated from sera of children with OMS and NB was measured by the expression of the activation marker, cytokines, and NO. Neuronal cytolysis was determined after exposing to IgG-treated microglia-conditioned media. Using inhibitors and activators, the effects of NO synthesis and its intracellular cascade, namely soluble guanylyl cyclase (sGC) and protein kinase G (PKG), on neuronal cytolysis were evaluated. Results: Incubation with sera or IgG from children with OMS and NB increased the activation of cerebral cortical and cerebellar microglias, but not the activation of astrocytes or the cytolysis of glial cells. Moreover, the cytolysis of neurons was elevated by conditioned media from microglias incubated with IgG from children with OMS and NB. Furthermore, the expression of NO, sGC, and PKG was increased. Neuronal cytolysis was relieved by the inhibitors of NO signaling, while neuronal cytolysis was exacerbated by the activators of NO signaling but not proinflammatory cytokines. The cytolysis of neurons was suppressed by pretreatment with the microglial inhibitor minocycline, a clinically tested drug. Finally, increased microglial activation did not depend on the Fab fragment of serum IgG. Conclusions: Serum IgG from children with OMS and NB potentiates microglial activation, which induces neuronal cytolysis through the NO/sGC/PKG pathway, suggesting an applicability of microglial inhibitor as a therapeutic candidate.Keywords
All Related Versions
Funding Information
- the BeiJing Talents Fund (2015000021469G204)
- the Basic Medicine and Clinical Medicine Cooperation Fund of Capital Medical University (15JL70, 16JL20)
- the Scientific Research Cultivation Fund of Capital Medical University (PYZ19030)
This publication has 59 references indexed in Scilit:
- Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disordersJournal of the Neurological Sciences, 2013
- Investigating neuroblastoma in childhood opsoclonus-myoclonus syndromeArchives of Disease in Childhood, 2011
- Opsoclonus–myoclonus in children associated or not with neuroblastomaEuropean Journal of Paediatric Neurology, 2010
- Opsoclonus–myoclonus–ataxia syndrome with autoantibodies to glutamic acid decarboxylaseClinical Neurology and Neurosurgery, 2008
- Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: Role of microgliaNeurochemistry International, 2007
- Species differences in the localization of soluble guanylyl cyclase subunits in monkey and rat brainJournal of Comparative Neurology, 2006
- Clinical potential of minocycline for neurodegenerative disordersNeurobiology of Disease, 2004
- Protein Kinase G Type II Is Required for Night-to-Day Progression of the Mammalian Circadian ClockNeuron, 2004
- NO induces a cGMP‐independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cellsFEBS Letters, 1999
- Myoclonic encephalopathy and diabetes mellitus in a boyDevelopmental Medicine & Child Neurology, 1999